Literature DB >> 18825316

Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.

Mikhail F Chernov1, Takakazu Kawamata, Kosaku Amano, Yuko Ono, Takashi Suzuki, Ryoichi Nakamura, Yoshihiro Muragaki, Hiroshi Iseki, Osami Kubo, Tomokatsu Hori, Kintomo Takakura.   

Abstract

The objective of the present study was investigation of the possible role of proton magnetic resonance spectroscopy ((1)H-MRS) for differential diagnosis of suprasellar tumors. Forty patients (23 men and 17 women; median age, 45 years) with suprasellar, hypothalamic, and third ventricle neoplasms underwent long-echo (TR: 2000 ms, TE: 136 ms, 128-256 acquisitions) single-voxel (1)H-MRS before surgical treatment. The volume of the voxel was either 3.4 cc or 8 cc. Spectroscopic data were analyzed by calculation of the various metabolite ratios as well as by determination of the type of the pathological (1)H-MR spectra. There were 19 pituitary adenomas, 7 gliomas, 5 craniopharyngiomas, 3 chordomas, meningioma, hemangiopericytoma, malignant lymphoma, germinoma, Rathke cleft cyst, and hypothalamic hamartoma (one of each). Six tumors were recurrent after initial surgical resection with or without irradiation. Comparison of the individual metabolite ratios revealed only few subtle differences among neoplasms. In the same time, pattern analysis with determination of the type of the pathological (1)H-MR spectra disclosed certain specific characteristics, which seemingly can be used for tumor typing. Meanwhile, metabolic imaging was less effective for characterization of recurrent neoplasms. In conclusion, in cases of initially diagnosed suprasellar tumors with involvement of the hypothalamus and extension into the third ventricle pattern analysis of the single-voxel (1)H-MRS can provide valuable information, which, in addition to structural MRI, can be effectively used for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825316     DOI: 10.1007/s11060-008-9698-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

Review 1.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

2.  Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.

Authors:  N Kunii; T Abe; M Kawamo; D Tanioka; H Izumiyama; T Moritani
Journal:  Acta Neurochir (Wien)       Date:  2007-07-09       Impact factor: 2.216

3.  Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database.

Authors:  Margarida Julià-Sapé; Dionisio Acosta; Carles Majós; Angel Moreno-Torres; Pieter Wesseling; Juan José Acebes; John R Griffiths; Carles Arús
Journal:  J Neurosurg       Date:  2006-07       Impact factor: 5.115

4.  Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.

Authors:  A Falini; G Calabrese; D Origgi; S Lipari; F Triulzi; M Losa; G Scotti
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

5.  Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.

Authors:  Mikhail F Chernov; Motohiro Hayashi; Masahiro Izawa; Yuko Ono; Tomokatsu Hori
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

6.  Differentiation of High-Grade and Low-Grade Gliomas Using Pattern Analysis of Long-Echo Single-Voxel Proton Magnetic Resonance Spectroscopy ((1)H-MRS).

Authors:  M F Chernov; Y Ono; Y Muragaki; O Kubo; R Nakamura; H Iseki; T Hori; K Takakura
Journal:  Neuroradiol J       Date:  2008-06-03

Review 7.  Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.

Authors:  Tracy Richmond McKnight
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

Review 8.  Imaging of sellar and parasellar lesions.

Authors:  Janine Rennert; Arnd Doerfler
Journal:  Clin Neurol Neurosurg       Date:  2006-11-28       Impact factor: 1.876

Review 9.  Clinical applications of proton MR spectroscopy in oncology.

Authors:  Lester Kwock; J Keith Smith; Mauricio Castillo; Matthew G Ewend; Sharon Cush; Thomas Hensing; Mahesh Varia; David Morris; Thomas W Bouldin
Journal:  Technol Cancer Res Treat       Date:  2002-02

10.  Application of MR spectroscopy and treatment approaches in a patient with extrapituitary growth hormone secreting macroadenoma.

Authors:  Dusko Kozic; Milica Medic-Stojanoska; Jelena Ostojic; Ljubomir Popovic; Nada Vuckovic
Journal:  Neuro Endocrinol Lett       Date:  2007-10       Impact factor: 0.765

View more
  7 in total

1.  Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.

Authors:  Hiromitsu Iwata; Kengo Sato; Koshi Tatewaki; Naoki Yokota; Mitsuhiro Inoue; Yoshimi Baba; Yuta Shibamoto
Journal:  Neuro Oncol       Date:  2011-06-10       Impact factor: 12.300

Review 2.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

3.  Clinical Relevance of Single-Voxel (1)H MRS Metabolites in Discriminating Suprasellar Tumors.

Authors:  A Einstien; Rahul A Virani
Journal:  J Clin Diagn Res       Date:  2016-07-01

4.  Comparison of post-surgical MRI presentation of the pituitary gland and its hormonal function.

Authors:  Joanna Bladowska; Violetta Sokolska; Tomasz Sozański; Grażyna Bednarek-Tupikowska; Marek Sąsiadek
Journal:  Pol J Radiol       Date:  2010-01

5.  A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment.

Authors:  G Manenti; F Di Giuliano; A Bindi; V Liberto; V Funel; F G Garaci; R Floris; G Simonetti
Journal:  Case Rep Radiol       Date:  2013-05-23

Review 6.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

7.  Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions.

Authors:  Navzer D Sachinvala; Angeline Stergiou; Duane E Haines; Armen Kocharian; Andrew Lawton
Journal:  Brain Sci       Date:  2019-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.